XXII Jan 2025 3.000 call
| Previous Close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 3.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.0500 - 0.0500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 470 |
Newsfile22nd Century Group Reports First Quarter 2024 Financial Results
New Contracts to Boost Second Quarter RevenueReduced Operating Costs, Improved Cash Position Reduced ~$8.0 Million of Outstanding Debt and Liabilities for Equity Exchanges in Q2 2024Mocksville, North Carolina--(Newsfile Corp. - May 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the first quarter ended March 31, 2024, and provided an update on recent business highlights. First Quarter 2024 Financial Re
Newsfile22nd Century Eliminates an Additional $2.3 Million of Debt
Continues to Improve Balance Sheet and Move Toward Cash Positive Operations Mocksville, North Carolina--(Newsfile Corp. - May 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement to eliminate an additional $2.3 million in outstanding debt with JGB Capital. Under the terms of the agreement, the Company and JGB Capital will exchange an aggregate of ...
Newsfile22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024
Mocksville, North Carolina--(Newsfile Corp. - May 8, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Aegis Capital Virtual Conference on Thursday, May 9, 2024 at 2:30 PM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/. About 22nd Century Group, Inc.22nd Century Group, Inc. (Nasdaq: XXII) is an agricultural biotechnology ...
